References
1. Velásquez-Jones L, Medeiros-Domingo M. Nephrogenic diabetes insipidus. Bol Méd Hosp Infant México Engl Ed. 2014 Nov 1;71(6):332–8.
2. Kalra S, Zargar AH, Jain SM, Sethi B, Chowdhury S, Singh AK, et al. Diabetes insipidus: The other diabetes. Indian J Endocrinol Metab. 2016;20(1):9–21.
3. Khanna A. Acquired nephrogenic diabetes insipidus. Semin Nephrol. 2006 May;26(3):244–8.
4. Huang C-L, Kuo E. Mechanism of Hypokalemia in Magnesium Deficiency. J Am Soc Nephrol. 2007 Oct 1;18(10):2649–52.
5. Radin MJ, Yu M-J, Stoedkilde L, Miller RL, Hoffert JD, Frokiaer J, et al. Aquaporin-2 Regulation in Health and Disease. Vet Clin Pathol Am Soc Vet Clin Pathol. 2012 Dec;41(4):455–70.
6. Moeller HB, Rittig S, Fenton RA. Nephrogenic Diabetes Insipidus: Essential Insights into the Molecular Background and Potential Therapies for Treatment. Endocr Rev. 2013 Apr;34(2):278–301.
7. Khositseth S, Uawithya P, Somparn P, Charngkaew K, Thippamom N, Hoffert JD, et al. Autophagic degradation of aquaporin-2 is an early event in hypokalemia-induced nephrogenic diabetes insipidus. Sci Rep [Internet]. 2015 Dec 17 [cited 2020 Nov 25];5. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682130/
8. Khositseth S, Charngkaew K, Boonkrai C, Somparn P, Uawithya P, Chomanee N, et al. Hypercalcemia induces targeted autophagic degradation of aquaporin-2 at the onset of nephrogenic diabetes insipidus. Kidney Int. 2017 May 1;91(5):1070–87.
9. Chakraborti S, Chakraborti T, Mandal M, Mandal A, Das S, Ghosh S. Protective role of magnesium in cardiovascular diseases: a review. Mol Cell Biochem. 2002 Sep;238(1–2):163–79.